Skip to main content
Clinical Trials/ISRCTN10554129
ISRCTN10554129
Active, not recruiting
Phase 1

A pilot study to identify the feasibility for a definitive study that will investigate the effectiveness of pacing with a heart rate monitor for people with myalgic encephalomyelitis and long COVID

niversity of Liverpool0 sites47 target enrollmentOctober 26, 2022

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Liverpool
Enrollment
47
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 26, 2022
End Date
June 30, 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
niversity of Liverpool

Eligibility Criteria

Inclusion Criteria

  • 1\. The International Consensus Criteria for Myalgic Encephalomyelitis will be used for people with ME and the presence of post\-exertional malaise (PEM) will be part of the inclusion criteria for people with long COVID
  • 2\. People with different severities of ME will be recruited ranging from mild to moderate ME

Exclusion Criteria

  • 1\. People with severe and very severe ME
  • 2\. People who are already using pacing with a heart rate monitor
  • 3\. People with long COVID without PEM

Outcomes

Primary Outcomes

Not specified

Similar Trials